JNJ-64164711
JNJ-64164711 (JNJ-711) is a bifunctional antibody that simultaneously targets human GITR/TNFRSF18 and FcγRIIIa. JNJ-64164711 binds to the GITR domain to activate the NF-κB signaling pathway, while binding to FcγRIIIa to support antibody-dependent cellular cytotoxicity (ADCC). JNJ-64164711 can specifically eliminate GITR-positive hematological tumor cells, activated T cells and intratumoral regulatory T cells through the ADCC mechanism, thereby significantly enhancing the body's anti-tumor immune response. JNJ-64164711 can be used in research related to non-small cell lung cancer, colorectal cancer, prostate cancer, renal cell carcinoma and hematological tumors.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human
JNJ-64164711 binds human GITR with high affinity (Kd = 180 pM), interacts with human FcγRIIIa variants, targets the CRD1 domain of GITR, and does not inhibit GITR-GITRL binding[1].
JNJ-64164711 mediates greater ADCC-driven depletion of GITR+ HuT102, KMS-12-BM, RPMI 8226, JJN-3 cell lines, primary activated GITR+ T cells, and in vitro expanded Tregs than other clinical-stage GITR agonist monoclonal antibodies[1].
JNJ-64164711 selectively depletes intratumoral effector Tregs in dissociated primary human patient tumor samples[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
TNFRSF18/GITR/CD357
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
Synonyms
JNJ-711
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- JNJ-64164711
- JNJ-711
- JNJ64164711
- JNJ 64164711
- JNJ711
- JNJ 711
- TNF Receptor
- NF-κB
- NF-kB signaling
- hematologic tumor cells
- regulatory T cells
- GITR
- human FcγRIIIa
- human glucocorticoid-induced tumor necrosis factor receptor-related protein
- non-small cell lung carcinoma
- TNFRSF18
- antibody dependent cellular cytotoxicity
- CRD1 domain
- Inhibitor
- inhibitor
- inhibit